Average Co-Inventor Count = 5.73
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (600 from 3,198 patents)
2. Genetech, Inc. (21 from 98 patents)
3. Genomic Health, Inc. (7 from 59 patents)
4. Psomagen, Inc. (2 from 35 patents)
5. Genenetech, Inc. (1 from 1 patent)
6. Genentch, Inc. (1 from 1 patent)
7. Ubiome, Inc. (59 patents)
632 patents:
1. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer
2. 11783914 - Method and system for panel characterizations
3. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer
4. 11572555 - Method and system for CRISPR-based library preparation and sequencing
5. 11551782 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
6. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer
7. 10260104 - Method for using gene expression to determine prognosis of prostate cancer
8. 10181008 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
9. 9551034 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer
10. 8628777 - Antibodies binding IL-1 related polypeptides
11. 8455217 - Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof
12. 8349329 - Antibodies that bind to PRO286
13. 8350008 - WISP polypeptides and nucleic acids encoding same
14. 8338132 - Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof
15. 8273703 - IL-17 receptor-like polypeptides and therapeutic uses thereof